Dr. Pratx's laboratory's goal is to develop the next generation of tools for improving cancer research and cancer care.

The Walbot Lab has intriguing clues that a novel type of small RNA (phasiRNAs = phased small RNAs of 21 or 24 nucleotides) are critical for early steps in in anther development.

Dr. Poston'’s research interests include the development, validation and application of functional and structural neuroimaging as biomarkers for the diagnosis and treatment of movement disorders.

Research in the Villeneuve lab is aimed at understanding the molecular and cellular mechanisms underlying the faithful inheritance and function of eukaryotic chromosomes.

Dr. Popelka currently focusses his efforts on several basic neuroscience issues and creating and developing effective invasive and non-invasive neuromodulation intervention for tinnitus and other neurologic conditions.

Dr. Vasanawala's group is focused on developing new MRI techniques, and in particular, developing novel applications for children.

Research in the Van de Rijn and West Lab focuses on gene microarray analysis of human soft tissue tumors (sarcomas).

The Urban lab is investigating the effects of variation in human genomes on normal and abnormal brain development and function.

Dr. Turakhia's research program aims to improve the treatment of heart rhythm disorders by understanding system- and patient-level variation of arrhythmia treatment in Veterans and their relationship to outcomes.

Dr. Porzig's current research is in early human developmental biology, organogenesis, and sex determination in embryogenesis.